Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.3, Iss.6, 2002-01, pp. : 431-434
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs in R&D, Vol. 3, Iss. 6, 2002-01 ,pp. :
Access to resources
Recommend
Ximelagatran [Exanta; AstraZeneca] has experienced a setback in the EU mutual recognition procedure
Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. :
Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 1, 2003-02 ,pp. :
Reproductive BioMedicine Online, Vol. 10, Iss. 1, 2005-01 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. :